Story
Increase product value using packaging and Instructions informed by unique market insights.
Challenge
Ortho McNeil had an improved form of an existing medication for children with ADHD. They wanted to avoid looking like a ”me too” company when entering an already crowded marketplace.
Solution
CharlesGroup worked with leading clinical experts & created a solution: Improve total patient care by increasing the child’s involvement in his/her care regimen. Concerta, marketed utilizing CharlesGroup’s ’Total solution’ strategy, helped position ALZA for its acquisition by J&J.

Ortho-McNeil

Ortho-McNeil’s plan: introduce a new form of an existing medication for children with attention deficit hyperactivity disorder (ADHD). They wanted to avoid looking like a ”me too” company when entering an already crowded marketplace.

CharlesGroup research examined the dynamic between children with ADHD and their caregivers, consulted with industry experts, and found a solution: improve total patient care by increasing the child’s involvement in his/her care regimen. Drug and behavioral therapy combined for a total solution.

CharlesGroup worked with leading clinical experts and created a report system that enables the child to be central in generating and managing the information about his/her behavior. Concerta, marketed utilizing CharlesGroup’s total solution strategy, is a powerful commercial success. Its success helped position ALZA for its acquisition by J&J. Sales of Concerta exceeded one billion dollars a year.